BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15652949)

  • 21. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
    Rabkin SW
    Vasa; 2014 Nov; 43(6):433-42. PubMed ID: 25339161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
    Manabe T; Imoto K; Uchida K; Doi C; Takanashi Y
    Surg Today; 2004; 34(3):220-5. PubMed ID: 14999533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms.
    McKellar SH; Tester DJ; Yagubyan M; Majumdar R; Ackerman MJ; Sundt TM
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):290-6. PubMed ID: 17662764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation of TIMPs in ascending aorta aneurysms.
    Tsarouhas K; Soufla G; Apostolakis S; Zaravinos A; Panagiotou M; Khoury M; Hassoulas JA; Tsatsakis AM; Spandidos DA
    Thromb Res; 2010 Nov; 126(5):399-405. PubMed ID: 20863553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in the remodeling of aneurysms of the ascending aorta with tricuspid aortic valves.
    Kirsch EW; Radu NC; Gervais M; Allaire E; Loisance DY
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1010-6. PubMed ID: 17059916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors.
    Ikonomidis JS; Ruddy JM; Benton SM; Arroyo J; Brinsa TA; Stroud RE; Zeeshan A; Bavaria JE; Gorman JH; Gorman RC; Spinale FG; Jones JA
    Ann Thorac Surg; 2012 Feb; 93(2):457-63. PubMed ID: 22206960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological grading of ascending aortic aneurysm: comparison of patients with bicuspid versus tricuspid aortic valve.
    Matthias Bechtel JF; Noack F; Sayk F; Erasmi AW; Bartels C; Sievers HH
    J Heart Valve Dis; 2003 Jan; 12(1):54-9; discussion 59-61. PubMed ID: 12578337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
    Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
    Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
    Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
    Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
    Määttä M; Tervahartiala T; Vesti E; Airaksinen J; Sorsa T
    J Glaucoma; 2006 Jun; 15(3):229-37. PubMed ID: 16778646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and biomolecular changes in aorta and pulmonary trunk of patients with aortic aneurysm and valve disease: implications for the Ross procedure.
    Schmid FX; Bielenberg K; Holmer S; Lehle K; Djavidani B; Prasser C; Wiesenack C; Birnbaum D
    Eur J Cardiothorac Surg; 2004 May; 25(5):748-53. PubMed ID: 15082277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
    Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
    Dreger SA; Taylor PM; Allen SP; Yacoub MH
    J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.